U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H10NO.Na
Molecular Weight 135.1395
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM CAPROLACTAMATE

SMILES

[Na+].O=C1CCCCC[N-]1

InChI

InChIKey=MOMGDEWWZBKDDR-UHFFFAOYSA-M
InChI=1S/C6H11NO.Na/c8-6-4-2-1-3-5-7-6;/h1-5H2,(H,7,8);/q;+1/p-1

HIDE SMILES / InChI
Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C6H11NO
Molecular Weight 113.1576
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:39:38 UTC 2023
Edited
by admin
on Sat Dec 16 08:39:38 UTC 2023
Record UNII
12PV43MR7E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM CAPROLACTAMATE
Common Name English
CAPROLACTAM SODIUM SALT
Common Name English
BRUGGOLEN C 10
Brand Name English
ADDONYL NL
Brand Name English
SODIUM CAPROLACTAM
Common Name English
2H-AZEPIN-2-ONE, HEXAHYDRO-, SODIUM SALT
Common Name English
HEXAHYDRO-2H-AZEPIN-2-ONE, SODIUM SALT; CAPROLACTAM, SODIUM SALT
Common Name English
2H-AZEPIN-2-ONE, HEXAHYDRO-, SODIUM SALT (1:1)
Systematic Name English
Code System Code Type Description
CAS
2123-24-2
Created by admin on Sat Dec 16 08:39:38 UTC 2023 , Edited by admin on Sat Dec 16 08:39:38 UTC 2023
PRIMARY
FDA UNII
12PV43MR7E
Created by admin on Sat Dec 16 08:39:38 UTC 2023 , Edited by admin on Sat Dec 16 08:39:38 UTC 2023
PRIMARY
EPA CompTox
DTXSID50890554
Created by admin on Sat Dec 16 08:39:38 UTC 2023 , Edited by admin on Sat Dec 16 08:39:38 UTC 2023
PRIMARY
PUBCHEM
10964565
Created by admin on Sat Dec 16 08:39:38 UTC 2023 , Edited by admin on Sat Dec 16 08:39:38 UTC 2023
PRIMARY
ECHA (EC/EINECS)
218-336-3
Created by admin on Sat Dec 16 08:39:38 UTC 2023 , Edited by admin on Sat Dec 16 08:39:38 UTC 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966